Cannell & Co. Astrazeneca PLC Transaction History

Cannell & Co.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $3.14 Million - $3.4 Million	-44,910 Reduced 43.99%	57,185 $4.09 Million
Q1 2023 May 08, 2023	SELL	$63.15 - $71.6 $11.3 Million - $12.9 Million	-179,725 Reduced 63.77%	102,095 $7.09 Million
Q4 2022 Feb 03, 2023	BUY	$54.21 - $70.44 $15.3 Million - $19.9 Million	281,820 New	281,820 $19.1 Million
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $1.32 Million - $1.59 Million	22,325 Added 3.24%	711,095 $47 Million
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $23.6 Million - $28.4 Million	423,150 Added 159.31%	688,770 $45.7 Million
Q4 2021 Feb 09, 2022	BUY	$54.02 - $63.83 $14.3 Million - $17 Million	265,620 New	265,620 $15.5 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.